Q-Medica Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Daskroi, Gujarat, India, established in 2020.
2020 Daskroi, Gujarat, India Active
Last Updated:
Access Report
About Q-Medica Pharmaceuticals Private Limited

Q-Medica Pharmaceuticals Private Limited, a active private limited company, was established on 01 August 2020 in Daskroi, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24290GJ2020PTC115198. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.70 M.

Its leadership includes Nilam Patel (Director), Narendrakumar Amrutbhai Patel (Director). Its latest balance sheet filed on 31 March 2025. It is based at A-418 Celebration City Centre,, Gala Gymkhana Road, South Bopal,, Daskroi, Gujarat, 380058.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24290GJ2020PTC115198

  • Registration Number

    115198

  • Incorporation Date

    01 August 2020

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.70 M

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.70 M
  • Company Age 5 Year, 6 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Q-Medica Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Q-Medica Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Q-Medica Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Nilam Patel Director 01 Aug 2020 Current
Narendrakumar Amrutbhai Patel Director 09 May 2025 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Q-Medica Pharmaceuticals.
Q-Medica Pharmaceuticals revenue growth over time
Q-Medica Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Q-Medica Pharmaceuticals?

Unlock access to Q-Medica Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Q-Medica Pharmaceuticals?

Unlock and access historical data on people associated with Q-Medica Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Q-Medica Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Q-Medica Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Q-Medica Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    The activity Narendrakumar Amrutbhai Patel was appointed as a Director was appointed as a Director on 09 May 2025 & has been associated with this company since 9 months 18 days . was completed.

  • Balance Sheet

    Q-Medica Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.

  • Director Appointment

    The activity Nilam Patel was appointed as a Director was appointed as a Director on 01 Aug 2020 & has been associated with this company since 5 years 6 months . was completed.

  • Company Incorporation

    Q-Medica Pharmaceuticals Private Limited was registered on 01 Aug 2020 with Roc Ahmedabad & aged 5 years 6 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Q-Medica Pharmaceuticals Private Limited?

The CIN of Q-Medica Pharmaceuticals Private Limited is U24290GJ2020PTC115198.

Where is Q-Medica Pharmaceuticals Private Limited headquartered?

Q-Medica Pharmaceuticals Private Limited is headquartered at A-418 Celebration City Centre,, Gala Gymkhana Road, South Bopal,, Daskroi, Gujarat, 380058.

When was Q-Medica Pharmaceuticals Private Limited incorporated?

Q-Medica Pharmaceuticals Private Limited was incorporated on 01 August 2020.

Who are the current directors of Q-Medica Pharmaceuticals Private Limited?

The current directors of Q-Medica Pharmaceuticals Private Limited are

What is the primary industry of Q-Medica Pharmaceuticals Private Limited?

The primary industry of Q-Medica Pharmaceuticals Private Limited is Manufacturing.

Is Q-Medica Pharmaceuticals Private Limited a listed company?

Q-Medica Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Q-Medica Pharmaceuticals Private Limited?

The authorized capital of Q-Medica Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.70 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available